Know more

About cookies

What is a "cookie"?

A "cookie" is a piece of information, usually small and identified by a name, which may be sent to your browser by a website you are visiting. Your web browser will store it for a period of time, and send it back to the web server each time you log on again.

Different types of cookies are placed on the sites:

  • Cookies strictly necessary for the proper functioning of the site
  • Cookies deposited by third party sites to improve the interactivity of the site, to collect statistics

Learn more about cookies and how they work

The different types of cookies used on this site

Cookies strictly necessary for the site to function

These cookies allow the main services of the site to function optimally. You can technically block them using your browser settings but your experience on the site may be degraded.

Furthermore, you have the possibility of opposing the use of audience measurement tracers strictly necessary for the functioning and current administration of the website in the cookie management window accessible via the link located in the footer of the site.

Technical cookies

Name of the cookie


Shelf life

CAS and PHP session cookies

Login credentials, session security



Saving your cookie consent choices

12 months

Audience measurement cookies (AT Internet)

Name of the cookie


Shelf life


Trace the visitor's route in order to establish visit statistics.

13 months


Store the anonymous ID of the visitor who starts the first time he visits the site

13 months


Identify the numbers (unique identifiers of a site) seen by the visitor and store the visitor's identifiers.

13 months

About the AT Internet audience measurement tool :

AT Internet's audience measurement tool Analytics is deployed on this site in order to obtain information on visitors' navigation and to improve its use.

The French data protection authority (CNIL) has granted an exemption to AT Internet's Web Analytics cookie. This tool is thus exempt from the collection of the Internet user's consent with regard to the deposit of analytics cookies. However, you can refuse the deposit of these cookies via the cookie management panel.

Good to know:

  • The data collected are not cross-checked with other processing operations
  • The deposited cookie is only used to produce anonymous statistics
  • The cookie does not allow the user's navigation on other sites to be tracked.

Third party cookies to improve the interactivity of the site

This site relies on certain services provided by third parties which allow :

  • to offer interactive content;
  • improve usability and facilitate the sharing of content on social networks;
  • view videos and animated presentations directly on our website;
  • protect form entries from robots;
  • monitor the performance of the site.

These third parties will collect and use your browsing data for their own purposes.

How to accept or reject cookies

When you start browsing an eZpublish site, the appearance of the "cookies" banner allows you to accept or refuse all the cookies we use. This banner will be displayed as long as you have not made a choice, even if you are browsing on another page of the site.

You can change your choices at any time by clicking on the "Cookie Management" link.

You can manage these cookies in your browser. Here are the procedures to follow: Firefox; Chrome; Explorer; Safari; Opera

For more information about the cookies we use, you can contact INRAE's Data Protection Officer by email at or by post at :


24, chemin de Borde Rouge -Auzeville - CS52627 31326 Castanet Tolosan cedex - France

Last update: May 2021

Menu Logo Principal logo Université Clermont Auvergne & associés

Human Nutrition Unit

Zone de texte éditable et éditée et rééditée



Professor of Universities (Pharm D/Ph D)

photo fcc

Email : contact
Phone : +33(0)4 73 17 79 71


The main objective of the ECREIN team is to characterise the immunocompetent cells' (CICs, ie immune cells, adipocytes, endothelials, epithelials, chondrocytes) response to microenvironment variations. This program is in the immunonutrition area with two major aims:

1) To identify the interrelationships between immunological/inflammatory alterations and metabolic disorders in relation to the nutritional status in physio-pathological conditions (in particular ageing, cancer, obesity, osteoarticular pathologies, allergy and food intolerance).

2) To maintain/optimize the responsiveness of the immunocompetent cells through nutritional interventions in a preventive and/or therapeutic way. To do this, a modulation strategy of the dialogue between CICs and other tissues (breast, intestine, bone in particular) is developed through the use the immunomodulatory bioactives (pre and probiotics, vitamin D, plant bioactives), in order to prevent the risk of chronic pathology associated with aging.

In this context, we select and evaluate plants/bioactives of naturally origin that have an effect on the immunocompetent cells thanks to our combined expertise in phytochemistry and biology.


The main objective of the work conducted is to characterize the response of immunocompetent cells (CICs, ie immune cells, adipocytes, endothelials, epithelials, chondrocytes) to variations in their micro-environment with two major endpoints:

1) To identify the relationships between immunological/inflammatory alterations and metabolic disorders related to nutritional and immune status in physio-pathological conditions (in particular aging, cancer). In this perspective, our work is more specifically focused on the study of the interactions between breast epithelial cells (immunocompetent barrier cells) and their microenvironment (adipocytic, immune and inflammatory) in obese situations, which is known to be a risk factor for breast cancer occurrence and relapse in post-menopausal women.

2) To maintain/optimize the immunocompetent cells' response capacities by providing nutritional interventions in a preventive and/or therapeutic approach. To achieve this, a strategy for modulation of the CIC microenvironment is developed by the use of immunomodulatory food plant bioactives , in order to prevent the potential risk of chronic pathologies that are associated with an inflammatory state (obesity, arthrosis...) which impairs mobility. Example of a project: FRI CLUSTER PLANTINAUV PROJECT. (please put a link to Plantinauv).

Our work is conducted in a transversal approach that combines original cellular (2 and 3D) and animal models (high-calorie diet, enriched environment) and clinical research protocols.


1: Cholet J, Decombat C, Vareille-Delarbre M, Gainche M, Berry A, Senejoux F, Ripoche I, Delort L, Vermerie M, Fraisse D, Felgines C, Ranouille E, Berthon JY, Priam J, Saunier E, Tourrette A, Troin Y, Thebaud G, Chalard P, Caldefie-Chezet F. In Vitro Anti-Inflammatory and Immunomodulatory Activities of an Extract from the Roots of Bupleurum rotundifolium. Medicines. 2019 Oct 11;6(4).

2: Bougaret L, Delort L, Billard H, Le Huede C, Boby C, De la Foye A, Rossary A, Mojallal A, Damour O, Auxenfans C, Vasson MP, Caldefie-Chezet F. Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen. PLoS One. 2018 Feb 1;13(2):e0191571.

3: Ramdani LH, Talhi O, Taibi N, Delort L, Decombat C, Silva A, Bachari K, Vasson MP, Caldefie-Chezet F. Effects of Spiro-bisheterocycles on Proliferation and Apoptosis in Human Breast Cancer Cell Lines. Anticancer Res. 2016 Dec;36(12):6399-6408.

4: Bougaret L, Delort L, Billard H, Lequeux C, Goncalves-Mendes N, Mojallal A, Damour O, Vasson MP, Caldefie-Chezet F. Supernatants of Adipocytes From Obese Versus Normal Weight Women and Breast Cancer Cells: In Vitro Impact on Angiogenesis. J Cell Physiol. 2017 Jul;232(7):1808-1816.

5: Delort L, Rossary A, Farges MC, Vasson MP, Caldefie-Chézet F. Leptin, adipocytes and breast cancer: Focus on inflammation and anti-tumor immunity. Life Sci. 2015 Nov 1;140:37-48. doi: 10.1016/j.lfs.2015.04.012. Epub 2015 May 6.



PharmD, University Professor, ECREIN Research Team Leader (UNH, UMR 1019 INRA-UCA) and Head of the Pharmaceutical Plant and Fungal Sciences Teaching Laboratory (SVFp), UFR PHARMACIE.


Nutrition, immunocompetent cells, cancer, obesity, inflammation, organoids, plant and fungal sciences, plant / plant bioactives, macromyces


1997 Doctor in Pharmacy, Clermont-Ferrand;

1997 Master of Biological and Medical Sciences, Clermont-Ferrand;

1998 DEA in "Nutrition and Food Sciences", Clermont-Ferrand;

2002 PhD University "Nutrition-Health", Clermont-Ferrand ;

2006 HDR. Pharmacy: Specialization "Biology-Health", Clermont-Ferrand ;

2007 Qualification for PU CNU41 positions


Factor H: 22; 44 original publications, 7 reviews, 2 book chapters

1 patent, 1 SATT maturation program large center; 12 invited lectures, 25 oral communications, > 120 poster communications.


+15 programmes financed since 2006 (INCA, National League against Cancer, ARC, Cancéropôle CLARA, FRI CLUSTER, Regional Contract; ERDF)


12 Post-Doctoral students and 13 foreign doctoral students.

Director of 5 PhD students at the University since 2006.


Congress Organization: 6 national and 2 international

Networks: Nacre, STOLON, D-2 ONCO-CLARA, Aviesan- " Organoid Multi-organism";

International collaborations: Sweden (Excellence Chair 2010-2012), Benin, Mali, Algeria, Côte d'Ivoire, Morocco, Turkey, Wales, Lebanon, Thailand.


UFR PHARMACIE-UCA: PACES selection committee since 2015; PACES triplements committee since 2015: teacher referring PACES; UFR pharmacy governance consulting; communication coordinator.

UNIVERSITY-UCA: Head of the CICAN'AUV platform (UCA Partner); UCA communication-referee since 2017.

UNH, UMR1019: Since 2017 head of the ECREIN research team and member of the UMR directional committee.

CANCEROPOLE CLARA: Scientific Council member since 2018, Nutrition referent; College for prevention and social innovations member since 2018